Gavin Reynolds is Honorary Professor in the Biomolecular Sciences Research Centre at Sheffield Hallam University and Professor Emeritus at Queen’s University Belfast. 

He also has an honorary research position at Rotherham, Doncaster and South Humber NHS Trust and has been President of the British Association for Psychopharmacology (2008-10).   

His main research interests lie in two overlapping directions: the neurotransmitter pathology of schizophrenia, with a recent focus on the epigenetic effect of environmental risk factors, and the mechanisms underlying beneficial and adverse effects of antipsychotics and other psychoactive drugs, particularly pharmacogenetic influences and cardiometabolic consequences. Additional interests include neurodegenerative disease mechanisms and biological effects of substance abuse. 

He has over 400 cited research publications with an h-index of 85 and >26000 citations (Google Scholar) and has international collaborations with Visiting Professor appointments at universities in Thailand and China.